Clinical Trials List
Protocol NumberSOA101-CL-Proto-01
Active
2025-06-01 - 2028-12-01
Phase I
Recruiting1
ICD-10C00.0
Malignant neoplasm of external upper lip
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9140.0
Malignant neoplasm of upper lip, vermilion border
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- Yao-Chung Wu 無
- Ching Yun Hsieh 無
- 方信元 無
- Tao-Wei Ke 無
- 王秀慈 無
- Ming-Yu Lien 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
184 participants
-
Global
184 participants
